Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 453 SEK 0.11% Market Closed
Market Cap: 14.3B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Xvivo Perfusion AB
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xvivo Perfusion AB
Net Income (Common) Peer Comparison

Comparables:
O
OSSD
D
DOXA
BACTI B
V
VIMIAN
S
S2M

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Xvivo Perfusion AB
STO:XVIVO
Net Income (Common)
kr204.3m
CAGR 3-Years
N/A
CAGR 5-Years
77%
CAGR 10-Years
41%
O
OssDsign AB
STO:OSSD
Net Income (Common)
-kr130.5m
CAGR 3-Years
-16%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Net Income (Common)
-kr208.2m
CAGR 3-Years
-165%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Bactiguard Holding AB
STO:BACTI B
Net Income (Common)
-kr138.4m
CAGR 3-Years
-53%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Net Income (Common)
€9.8m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Net Income (Common)
-kr1.9m
CAGR 3-Years
54%
CAGR 5-Years
34%
CAGR 10-Years
N/A

See Also

What is Xvivo Perfusion AB's Net Income (Common)?
Net Income (Common)
204.3m SEK

Based on the financial report for Sep 30, 2024, Xvivo Perfusion AB's Net Income (Common) amounts to 204.3m SEK.

What is Xvivo Perfusion AB's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
41%

Over the last year, the Net Income (Common) growth was 748%.

Back to Top